We are live on ! Find out more
AKBA icon

Akebia Therapeutics
AKBA

119 hedge funds and large institutions have $593M invested in Akebia Therapeutics in 2017 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 56 increasing their positions, 16 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

891% more call options, than puts

Call options by funds: $2.2M | Put options by funds: $222K

250% more repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 16

51% more capital invested

Capital invested by funds: $392M → $593M (+$202M)

9% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 22

1% more funds holding

Funds holding: 118 → 119 (+1)

0.19% less ownership

Funds ownership: 64.17% → 63.98% (-0.19%)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
119
Holders Change
+1
Holders Change %
+0.85%
% of All Funds
2.97%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
24
Increased
56
Reduced
16
Closed
22
Calls
$2.2M
Puts
$222K
Net Calls
+$1.98M
Net Calls Change
+$848K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$15.5M
2
PA
Perceptive Advisors
New York
+$8.15M
3
Invesco
Invesco
Georgia
+$7.19M
4
Norges Bank
Norges Bank
Norway
+$6.09M
5
Renaissance Technologies
Renaissance Technologies
New York
+$6.08M

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$12M
2
NCM
Nantahala Capital Management
Connecticut
-$12M
3
EAM
Eagle Asset Management
Florida
-$7.41M
4
CLCM
Crawford Lake Capital Management
New Jersey
-$4.65M
5
First Manhattan
First Manhattan
New York
-$4.24M
Name Holding Trade Value Shares
Change 		Change in
Stake
Los Angeles Capital Management
51
Los Angeles Capital Management
California
$1.04M +$815K +53,040 New
AQR Capital Management
52
AQR Capital Management
Connecticut
$1.01M +$794K +51,616 New
Prudential Financial
53
Prudential Financial
New Jersey
$971K +$759K +49,360 New
New York State Common Retirement Fund
54
New York State Common Retirement Fund
New York
$946K – – –
Allianz Asset Management
55
Allianz Asset Management
Germany
$933K +$729K +47,440 New
ADEF
56
Adams Diversified Equity Fund
Maryland
$930K +$727K +47,300 New
AA
57
ALPS Advisors
Colorado
$912K +$174K +11,323 +32%
SO
58
STRS Ohio
Ohio
$904K – – –
RhumbLine Advisers
59
RhumbLine Advisers
Massachusetts
$881K +$50K +3,255 +8%
AllianceBernstein
60
AllianceBernstein
Tennessee
$850K – – –
SCM
61
Sterling Capital Management
North Carolina
$844K +$660K +42,903 New
RJA
62
Raymond James & Associates
Florida
$725K +$4.93K +321 +0.9%
CS
63
Credit Suisse
Switzerland
$712K +$197K +12,838 +55%
Dimensional Fund Advisors
64
Dimensional Fund Advisors
Texas
$700K – – –
Manulife (Manufacturers Life Insurance)
65
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$681K +$75.4K +4,904 +16%
SIM
66
Spark Investment Management
New York
$625K – – –
PAM
67
Panagora Asset Management
Massachusetts
$593K – – –
MLICM
68
Metropolitan Life Insurance Company (MetLife)
New York
$589K +$94K +6,117 +26%
AIG
69
American International Group
New York
$585K +$105K +6,836 +30%
ProShare Advisors
70
ProShare Advisors
Maryland
$583K +$98.8K +6,424 +28%
PCM
71
Piermont Capital Management
Missouri
$546K -$420K -27,305 -50%
Citigroup
72
Citigroup
New York
$537K +$359K +23,321 +586%
State of Wisconsin Investment Board
73
State of Wisconsin Investment Board
Wisconsin
$511K – – –
FDCDDQ
74
Federation des caisses Desjardins du Quebec
Quebec, Canada
$484K +$377K +24,549 New
NFA
75
Nationwide Fund Advisors
Ohio
$467K +$36.3K +2,362 +11%
1 2
3
4 5

AKBA Hedge Fund Activity: Q3 2017 in Review

119 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Akebia Therapeutics (AKBA) for Q3 2017, worth a combined $593M — up 51% from $392M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new AKBA positions and 22 closed out — a net gain of 2 holders — while 56 added to existing stakes and 16 trimmed.

The largest buyer was BlackRock, adding an estimated $15.5M. The largest seller was RA Capital Management, exiting entirely with an estimated $12M sold.

  • 119 institutional investors held Akebia Therapeutics (AKBA) as of Q3 2017, up from 118 in Q2 2017.
  • Funds reported $593M of Akebia Therapeutics stock for Q3 2017, up 51% quarter-over-quarter.
  • 24 funds opened new Akebia Therapeutics positions in Q3 2017 and 22 closed out, a net change of +2 holders.
  • The largest Akebia Therapeutics buyer in Q3 2017 was BlackRock, an estimated $15.5M added.
  • The largest Akebia Therapeutics seller in Q3 2017 was RA Capital Management, an estimated $12M sold.

Based on aggregated 13F filings for Q3 2017.